SAGE Therapeutics (SAGE) Shares on Watch Amid Chatter
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
SAGE Therapeutics (Nasdaq: SAGE) shares are on watch amid market chatter that Kerrisdale Capital is no longer short the stock. Rumors are unconfirmed.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Cvent, Inc. (CVT) Active on Reports of DOJ Probe into Deal
- UPDATE: CIT Group (CIT) Hires Boston Consulting to Review Operations - DJ
- Apple (AAPL) October weekly volatility increases on more puts than calls into Q4
Create E-mail Alert Related CategoriesRumors, Short Sales, Trader Talk
Related EntitiesKerrisdale Capital
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!